# Aortic Regurgitation in a Patient with Rheumatoid Arthritis/Systemic Lupus Erythematosus Overlap Syndrome (Rhupus): Case Report and Review of Literature

**Authors:** Mislav Radić, Hana Đogaš, Tina Bečić, Petra Šimac, Ivana Jukić, Josipa Radić, Damir Fabijanić

PMC · DOI: 10.3390/jcdd12100408 · Journal of Cardiovascular Development and Disease · 2025-10-16

## TL;DR

A patient with rheumatoid arthritis and lupus developed aortic regurgitation, highlighting the need for heart monitoring in such patients.

## Contribution

This case report emphasizes the link between chronic inflammation in RA/SLE and aortic regurgitation as an extra-articular manifestation.

## Key findings

- A patient with RA/SLE overlap syndrome presented with moderate aortic regurgitation and preserved heart function.
- Chronic systemic inflammation in RA/SLE may contribute to the development of aortic regurgitation.
- Echocardiography is recommended for early detection of cardiovascular complications in rheumatologic patients.

## Abstract

Background/Objectives: Cardiovascular diseases (CVDs), including valvular heart disease (VHD), remain the leading cause of morbidity and mortality in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Case Presentation: We report a rare case of a woman in her fifth decade of life diagnosed with overlap syndrome (RA and SLE), in whom transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) revealed a degenerative altered bicuspid aortic valve with moderate aortic regurgitation (AR) and preserved left ventricular systolic function. The patient presented with a recent history of continuous, moderate chest discomfort and progressive exertional dyspnea, along with a mild elevation in highly cardioselective enzymes. AR was confirmed as the cause of her symptoms, rather than acute coronary syndrome or heart failure. Conclusions: This case highlights the potential contribution of chronic systemic inflammation in RA/SLE to the pathogenesis of AR, an extra-articular manifestation associated with adverse clinical outcomes. These findings support the routine use of echocadiography in rheumatologic patients as a key strategy for early detection and prevention of life-threatening CV complications.

## Linked entities

- **Diseases:** rheumatoid arthritis (MONDO:0008383), systemic lupus erythematosus (MONDO:0007915)

## Full-text entities

- **Diseases:** CVDs (MESH:D002318), Rhupus (MESH:D008180), overlap syndrome (MESH:D000080445), bicuspid aortic valve (MESH:D000082882), VHD (MESH:D006349), chronic systemic inflammation (MESH:D007249), acute coronary syndrome (MESH:D054058), AR (MESH:D001022), heart failure (MESH:D006333), RA (MESH:D001172), dyspnea (MESH:D004417), CV complications (MESH:D008107)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12564741/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12564741/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12564741/full.md

---
Source: https://tomesphere.com/paper/PMC12564741